These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23795862)

  • 61. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.
    Bachmann CJ; Lehr D; Theisen FM; Preiss M
    Pharmacopsychiatry; 2009 Jul; 42(4):153-7. PubMed ID: 19585394
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.
    Messer T; Schmauss M; Spevakne-Goeroecs T; Kungel M; Ebrecht M; Werner C; Modell S
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):231-8. PubMed ID: 20218786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.
    Chen CY; Lin TY; Wang CC; Shuai HA
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study.
    Dittmann RW; Meyer E; Freisleder FJ; Remschmidt H; Mehler-Wex C; Junghanss J; Hagenah U; Schulte-Markwort M; Poustka F; Schmidt MH; Schulz E; Mästele A; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):54-69. PubMed ID: 18294089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Switching to ziprasidone in the clinical practice setting: an open-label study.
    Gutiérrez Fraile M; de la Gándara Martín JJ; Bobes García J
    Int J Psychiatry Med; 2013; 45(2):125-42. PubMed ID: 23977817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.
    Pae CU; Chiesa A; Mandelli L; Patkar AA; Gibiino S; Serretti A
    Clin Drug Investig; 2010; 30(3):187-93. PubMed ID: 20155991
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.
    Schöttle D; Janetzky W; Luedecke D; Beck E; Correll CU; Wiedemann K
    BMC Psychiatry; 2018 Nov; 18(1):365. PubMed ID: 30428862
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.
    Takeuchi H; Remington G
    Psychopharmacology (Berl); 2013 Jul; 228(2):175-85. PubMed ID: 23736279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MB; Bilenberg N; Stenstrøm AD; Pedersen J; Nyvang L; Madsen S; Lauritsen MB; Vernal DL; Thomsen PH; Paludan J; Werge TM; Winge K; Juul K; Gluud C; Skoog M; Wetterslev J; Jepsen JR; Correll CU; Fink-Jensen A; Fagerlund B
    BMC Psychiatry; 2014 Jul; 14():199. PubMed ID: 25015535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia.
    Kane JM; Sanchez R; Zhao J; Duca AR; Johnson BR; McQuade RD; Eramo A; Baker RA; Peters-Strickland T
    J Med Econ; 2013 Jul; 16(7):917-25. PubMed ID: 23663091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
    Masi G; Cosenza A; Millepiedi S; Muratori F; Pari C; Salvadori F
    CNS Drugs; 2009; 23(6):511-21. PubMed ID: 19480469
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aripiprazole in schizophrenia with cocaine dependence: a pilot study.
    Beresford TP; Clapp L; Martin B; Wiberg JL; Alfers J; Beresford HF
    J Clin Psychopharmacol; 2005 Aug; 25(4):363-6. PubMed ID: 16012280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aripiprazole and perphenazine: no difference.
    Rosenheck RA
    J Clin Psychiatry; 2007 Nov; 68(11):1812-3; author reply 1813-4. PubMed ID: 18052580
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
    Zhou Z; Zhu H; Chen L
    PLoS One; 2013; 8(1):e52186. PubMed ID: 23308105
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
    Higuchi Y; Sumiyoshi T; Seo T; Miyanishi T; Kawasaki Y; Suzuki M
    PLoS One; 2013; 8(1):e54080. PubMed ID: 23349791
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.
    Aragona M
    Eat Weight Disord; 2007 Sep; 12(3):e54-7. PubMed ID: 17984630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.